SCHEMBL4365347

SCHEMBL4365347

N#Cc1ccc(C(=O)NC(=S)Nc2ccccc2OCc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.54
MEN1 O00255 6/20 0.54
TDP1 Q9NUW8 5/20 0.54
CTDSP1 Q9GZU7 1/20 0.53
BRD4 O60885 2/20 0.51
CYP19A1 P11511 1/20 0.49
POLB P06746 3/20 0.49
KCNH2 Q12809 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
GPR55 Q9Y2T6 1/20 0.48
ALDH1A1 P00352 3/20 0.47
MAPT P10636 3/20 0.47
KDM4E B2RXH2 2/20 0.47
ALOX12 P18054 2/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 2/20 0.47
EPHX1 P07099 2/20 0.47
NPC1 O15118 1/20 0.46
CASP3 P42574 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5838780 0.82 MEN1 (0.71) KMT2AMEN1TDP1CTDSP1POLB
SCHEMBL11160894 0.81 EPHX1 (0.55) KMT2AMEN1L3MBTL1ALDH1A1MAPT
SCHEMBL5993699 0.78 ADORA3 (0.53) KMT2AMEN1TDP1CTDSP1BRD4
SCHEMBL38660970 0.76 NPC1 (0.55) KMT2ATDP1BRD4L3MBTL1ALDH1A1
SCHEMBL38660185 0.76 BRD4 (0.70) KMT2AMEN1TDP1BRD4L3MBTL1
SCHEMBL11549645 0.76 BRD4 (0.70) KMT2AMEN1TDP1BRD4L3MBTL1
SCHEMBL2335910 0.75 EPHX1 (0.76) KMT2AMEN1TDP1POLBKCNH2
SCHEMBL5936687 0.75 BRD4 (0.65) KMT2AMEN1TDP1BRD4L3MBTL1
SCHEMBL19220942 0.74 TDP1 (0.61) KMT2AMEN1TDP1BRD4POLB
SCHEMBL7492629 0.73 CXCR2 (0.62) TDP1BRD4CYP19A1POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476686-B2 Substituted aryl thioureas and related compounds; inhibitors of viral replication ACHILLION PHARMACEUTICALS, INC. (US) 2009-01-13 US disclosed
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication CHEN DAWEI 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014836-A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication NAT1, PIGS, SLC10A1 KMT2A 1703/4885MEN1 4762/4885TDP1 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.